GRAIL, INC.
Profile
Company Names
GRAIL, INC.
Addresses
1525 O-BRIEN DRIVE, MENLO PARK, CA 94025
Phone Numbers
650-454-6995
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$2,228,060,543.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-10-21
$324,997,989.00
$324,997,989.00
$0.00
Equity
3
2019-11-27
$388,407,514.00
$425,000,000.00
$36,592,486.00
Equity
2
2018-05-16
$300,000,000.00
INDEFINITE
INDEFINITE
Equity
1
2017-02-28
$1,214,655,040.00
INDEFINITE
INDEFINITE
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
HANS
BISHOP
EXECUTIVE OFFICER, DIRECTOR
BROOK
BYERS
DIRECTOR
OPTIMEDICA CORP
| HX DIAGNOSTICS INC
| CRESCENDO BIOSCIENCE, INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| ELCELYX THERAPEUTICS, INC.
| FOUNDATION MEDICINE, INC.
| OCULEVE, INC.
| ENJOY TECHNOLOGY, INC.
| ZEPHYR HEALTH, INC.
| NEWSELA, INC.
| CAREDX, INC.
| CELL DESIGN LABS, INC.
| GRAIL, INC.
| OCTAVE BIOSCIENCE INC
| EPIODYNE, INC.
| ARSENAL BIOSCIENCES, INC.
JENNIFER
COOK
EXECUTIVE OFFICER, DIRECTOR
RICHARD
KLAUSNER
DIRECTOR
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
ROBERT
T.
NELSEN
DIRECTOR
WILLIAM
RASTETTER
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2025-10-21
D/A
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2019-11-27
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2019-11-27
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2018-05-16

